Company — Principia Biopharma
Focused on discovering and developing first-in-class small molecule drugs within the fields of autoimmune disease and oncology that are potent and safe. (NASDAQ: PRNB) (Acquired by Sanofi)
Focused on discovering and developing first-in-class small molecule drugs within the fields of autoimmune disease and oncology that are potent and safe. (NASDAQ: PRNB) (Acquired by Sanofi)